Sweden
· Delayed Price · Currency is SEK Spermosens AB Statistics
Total Valuation
Spermosens AB has a market cap or net worth of SEK 3.40 million. The enterprise value is 3.90 million.
| Market Cap | 3.40M |
| Enterprise Value | 3.90M |
Important Dates
The last earnings date was Thursday, November 28, 2024.
| Earnings Date | Nov 28, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Spermosens AB has 283.61 million shares outstanding. The number of shares has increased by 311.57% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 283.61M |
| Shares Change (YoY) | +311.57% |
| Shares Change (QoQ) | +101.35% |
| Owned by Insiders (%) | 28.29% |
| Owned by Institutions (%) | 18.74% |
| Float | 203.37M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 0.15 |
| P/TBV Ratio | 0.15 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.40 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -0.38 |
Financial Position
The company has a current ratio of 0.65, with a Debt / Equity ratio of 0.03.
| Current Ratio | 0.65 |
| Quick Ratio | 0.65 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.06 |
| Interest Coverage | -5.36 |
Financial Efficiency
Return on equity (ROE) is -32.23% and return on invested capital (ROIC) is -14.50%.
| Return on Equity (ROE) | -32.23% |
| Return on Assets (ROA) | -13.50% |
| Return on Capital (ROIC) | -14.50% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -3.25M |
| Employee Count | 7 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -97.64% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -97.64% |
| 50-Day Moving Average | 0.02 |
| 200-Day Moving Average | 0.07 |
| Relative Strength Index (RSI) | 45.04 |
| Average Volume (20 Days) | 6,100,415 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -8.21M |
| Pretax Income | -9.74M |
| Net Income | -9.74M |
| EBITDA | -8.03M |
| EBIT | -8.21M |
| Earnings Per Share (EPS) | -0.08 |
Balance Sheet
The company has 129,000 in cash and 626,000 in debt, giving a net cash position of -497,000 or -0.00 per share.
| Cash & Cash Equivalents | 129,000 |
| Total Debt | 626,000 |
| Net Cash | -497,000 |
| Net Cash Per Share | -0.00 |
| Equity (Book Value) | 21.97M |
| Book Value Per Share | 0.08 |
| Working Capital | -406,000 |
Cash Flow
In the last 12 months, operating cash flow was -10.12 million and capital expenditures -108,000, giving a free cash flow of -10.23 million.
| Operating Cash Flow | -10.12M |
| Capital Expenditures | -108,000 |
| Free Cash Flow | -10.23M |
| FCF Per Share | -0.04 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Spermosens AB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -311.57% |
| Shareholder Yield | -311.57% |
| Earnings Yield | -639.98% |
| FCF Yield | -300.53% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |